Nozu Kandai, Vorechovsky Igor, Kaito Hiroshi, Fu Xue Jun, Nakanishi Koichi, Hashimura Yuya, Hashimoto Fusako, Kamei Koichi, Ito Shuichi, Kaku Yoshitsugu, Imasawa Toshiyuki, Ushijima Katsumi, Shimizu Junya, Makita Yoshio, Konomoto Takao, Yoshikawa Norishige, Iijima Kazumoto
Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan;
Faculty of Medicine, University of Southampton, Southampton, United Kingdom;
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1958-64. doi: 10.2215/CJN.04140414. Epub 2014 Sep 2.
X-linked Alport syndrome is caused by mutations in the COL4A5 gene. Although many COL4A5 mutations have been detected, the mutation detection rate has been unsatisfactory. Some men with X-linked Alport syndrome show a relatively mild phenotype, but molecular basis investigations have rarely been conducted to clarify the underlying mechanism.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In total, 152 patients with X-linked Alport syndrome who were suspected of having Alport syndrome through clinical and pathologic investigations and referred to the hospital for mutational analysis between January of 2006 and January of 2013 were genetically diagnosed. Among those patients, 22 patients had suspected splice site mutations. Transcripts are routinely examined when suspected splice site mutations for abnormal transcripts are detected; 11 of them showed expected exon skipping, but others showed aberrant splicing patterns. The mutation detection strategy had two steps: (1) genomic DNA analysis using PCR and direct sequencing and (2) mRNA analysis using RT-PCR to detect RNA processing abnormalities.
Six splicing consensus site mutations resulting in aberrant splicing patterns, one exonic mutation leading to exon skipping, and four deep intronic mutations producing cryptic splice site activation were identified. Interestingly, one case produced a cryptic splice site with a single nucleotide substitution in the deep intron that led to intronic exonization containing a stop codon; however, the patient showed a clearly milder phenotype for X-linked Alport syndrome in men with a truncating mutation. mRNA extracted from the kidney showed both normal and abnormal transcripts, with the normal transcript resulting in the milder phenotype. This novel mechanism leads to mild clinical characteristics.
This report highlights the importance of analyzing transcripts to enhance the mutation detection rate and provides insight into genotype-phenotype correlations. This approach can clarify the cause of atypically mild phenotypes in X-linked Alport syndrome.
X连锁遗传性肾炎是由COL4A5基因突变引起的。尽管已检测到许多COL4A5突变,但突变检测率仍不尽人意。一些患有X连锁遗传性肾炎的男性表现出相对较轻的表型,但很少进行分子基础研究以阐明其潜在机制。
设计、地点、参与者及测量方法:2006年1月至2013年1月期间,共有152例经临床和病理检查怀疑患有遗传性肾炎并转诊至本院进行突变分析的X连锁遗传性肾炎患者接受了基因诊断。其中,22例患者怀疑存在剪接位点突变。当检测到可疑的剪接位点突变时,常规检查转录本是否存在异常转录本;其中11例表现出预期的外显子跳跃,但其他患者表现出异常的剪接模式。突变检测策略分两步:(1)使用聚合酶链反应(PCR)和直接测序进行基因组DNA分析;(2)使用逆转录聚合酶链反应(RT-PCR)进行mRNA分析以检测RNA加工异常。
鉴定出6个导致异常剪接模式的剪接共有序列位点突变、1个导致外显子跳跃的外显子突变以及4个产生隐蔽剪接位点激活的内含子深部突变。有趣的是,1例患者在深部内含子中发生单核苷酸替换产生了一个隐蔽剪接位点,导致内含子外显子化并包含一个终止密码子;然而,该患者在具有截短突变的男性X连锁遗传性肾炎患者中表现出明显较轻的表型。从肾脏提取的mRNA显示既有正常转录本也有异常转录本,正常转录本导致较轻的表型。这种新机制导致了轻微的临床特征。
本报告强调了分析转录本以提高突变检测率的重要性,并为基因型-表型相关性提供了见解。这种方法可以阐明X连锁遗传性肾炎非典型轻度表型的原因。